Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

BIZARRE: Agile rapeutics | Mind Blowing Facts

Benzinga's Top Ratings Upgrades, Downgrades For July 26, 2022

Upgrades

Benzinga · Jul 26, 2022

12 Health Care Stocks Moving In Friday's Intraday Session

Benzinga · Jul 1, 2022

12 Health Care Stocks Moving In Wednesday's Intraday Session

Gainers

Benzinga · Jun 29, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

Recap: Agile Therapeutics Q1 Earnings

Agile Therapeutics (NASDAQ:AGRX) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:05 PM. Here's what investors need to know about the announcement.

Benzinga · May 12, 2022

12 Health Care Stocks Moving In Tuesday's After-Market Session

Gainers

Benzinga · Apr 12, 2022

12 Health Care Stocks Moving In Tuesday's Intraday Session

Gainers

Benzinga · Apr 12, 2022

12 Health Care Stocks Moving In Monday's Intraday Session

Benzinga · Apr 4, 2022

Read news from The Economist, FT, and more,
with one subscription

Agile Therapeutics's Return On Capital Employed Insights

Benzinga Pro data, Agile Therapeutics (NASDAQ:AGRX) reported Q4 sales of $1.51 million. Earnings fell to a loss of $23.36 million, resulting in a 39.26% decrease from last quarter.

Benzinga · Mar 31, 2022

Preview: Agile Therapeutics's Earnings

Agile Therapeutics (NASDAQ:AGRX) is set to give its latest quarterly earnings report on Wednesday, 2022-03-30. Here's what investors need to know before the announcement. Analysts estimate that Agile Therapeutics will report an earnings per share (EPS) of $-0.15.

Benzinga · Mar 29, 2022

Coverage From

Benzinga

Organisations

American Eagle Outfitters

From analysis to the latest developments in health,
read the most diverse news in one place.

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.